However, previous studies have focused on the impact of Fgl2 produced from regulatory T cells, macrophages and tumor-associated cells (stroma, fibroblasts) as these cell types are known cellular sources of Fgl2 that can mediate immunosuppression on T cells28–30,32,33,40–42,45–49. This evidence concerns the gene FGL2 and neoplasm.